Effectiveness and tolerance of low to very low dose thalidomide in low-risk myelodysplastic syndromes

被引：11

作者：

Tamburini, J. ^{[1
]}

Elie, C. ^{[2
]}

Park, S. ^{[1
]}

Beyne-Rauzy, O. ^{[3
]}

Gardembas, M. ^{[4
]}

Berthou, C. ^{[5
]}

Mahe, B. ^{[6
]}

Sanhes, L. ^{[7
]}

Stamatoullas, A. ^{[8
]}

Vey, N. ^{[9
]}

Aouba, A.

Slama, B. ^{[10
]}

Quesnel, B. ^{[11
]}

Vekhoff, A. ^{[13
]}

Sotto, J. J. ^{[12
]}

Vassilief, D. ^{[1
]}

Al-Nawakil, C. ^{[1
]}

Fenaux, P. ^{[14
]}

Dreyfus, F. ^{[1
]}

Bouscary, D. ^{[1
]}

机构：

[1] Hop Cochin, Dept Haematol, Paris, France

[2] Univ Paris 05, Dept Biostat, F-75270 Paris 06, France

[3] Hop Purpan, Dept Hematol Odile, Toulouse, France

[4] Ctr Hosp Angers, Dept Hematol Martine, Angers, France

[5] Hop Brest, Dept Hematol Christian, Brest, France

[6] Ctr Hosp Nantes, Dept Hematol, Nantes, France

[7] Ctr Hosp Perpignan, Dept Hematol, Perpignan, France

[8] Ctr Hosp Rouen, Dept Hematol Aspasia, Rouen, France

[9] Inst J Paoli I Calmettes, Dept Hematol, F-13009 Marseille, France

[10] Ctr Hosp Avignon, Dept Hematol, Avignon, France

[11] Ctr Hosp Lille, Dept Hematol, Lille, France

[12] Ctr Hosp Grenoble, Dept Hematol, Grenoble, France

[13] Hop Hotel Dieu, Dept Hematol, F-75181 Paris, France

[14] Hop Avicenne, Dept Hematol, Bobigny, France

来源：

LEUKEMIA RESEARCH | 2009年 / 33卷 / 04期

关键词：

INTERNATIONAL WORKING GROUP; RESPONSE CRITERIA; ANEMIA; PROPOSAL;

D O I：

10.1016/j.leukres.2008.06.005

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：547 / 550

页数：4

共 50 条

[31] Low Risk Myelodysplastic Syndromes in Morocco
Fatih, Basma
Lamchahab, Mouna
Douma, Soukaina
Dahmaoui, Nizar
Oukkach, Bouchra
Rachid, Mohamed
Qachouh, Meryem
Cherkaoui, Siham
Khoubila, Nissrine
Madani, Abdellah
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S313 - S313
[32] INCORPORATION OF COHESIN MUTATIONAL DATA INTO CURRENT IPSS-R CLASSIFICATION REFINES THE PROGNOSTIC STRATIFICATION OF VERY LOW/LOW-RISK MYELODYSPLASTIC SYNDROMES
Martin Izquierdo, M.
Diez-Campelo, M.
Sanchez Del Real, J.
Hernandez Sanchez, A.
Hernandez Sanchez, J. M.
Janusz, K.
Lopez, F.
Tormo, M.
Megido, M.
Olivier, C.
Madinaveitia-Ochoa, A.
Davila, J.
Sierra, M.
Vargas, M.
Santos Minguez, S.
Miguel Garcia, C.
Benito, R.
Hernandez Rivas, J. M.
Ramos, F.
Abaigar, M.
LEUKEMIA RESEARCH, 2021, 108 : S15 - S16
[33] An accessible patient-derived xenograft model of low-risk myelodysplastic syndromes
Teodorescu, Patric
Pasca, Sergiu
Choi, Inyoung
Shams, Cynthia
Dalton, W. Brian
Gondek, Lukasz P.
DeZern, Amy E.
Ghiaur, Gabriel
HAEMATOLOGICA, 2024, 109 (01) : 337 - 342
[34] Moving low-risk myelodysplastic syndromes from humans to mice: is it truly that simple?
Coriu, Daniel
Stancioaica, Maria -Camelia
HAEMATOLOGICA, 2024, 109 (01) : 8 - 10
[35] The Management of Low-Risk Myelodysplastic Syndromes-Current Standards and Recent Advances
Randall, Michael P.
DeZern, Amy E.
CANCER JOURNAL, 2023, 29 (03): : 152 - 159
[36] HEPCIDIN AND ERYTHROFERRONE (ERFE) ARE NOT CORRELATED IN THE ANEMIA OF LOW-RISK MYELODYSPLASTIC SYNDROMES (MDS)
Redondo, S.
Oarbeascoa, G.
Moran Jimenez, M. J.
Domingo, A.
Munoz Linares, C.
Moreno Carralero, M. I.
Bellon, J. M.
Del Campo Rincon, J. F.
Diez-Martin, J. L.
Font, P.
HAEMATOLOGICA, 2018, 103 : 183 - 184
[37] Efficacy of growth factors compared to chemotherapy in low-risk myelodysplastic syndromes.
Golshayan, A
Fu, AZ
Kattan, MW
Brown, S
Maciejewski, JP
Sekeres, MA
BLOOD, 2005, 106 (11) : 713A - 714A
[38] Luspatercept: a candidate to dethrone erythropoietin in first line in low-risk myelodysplastic syndromes?
Robert-Van Houtteghem, Tristan
HEMATOLOGIE, 2023, 29 (05): : 269 - 271
[39] Efficacy of growth factors compared to other therapies for low-risk myelodysplastic syndromes
Golshayan, Ali-Reza
Jin, Tao
Maciejewski, Jaroslaw
Fu, Alex Z.
Bershadsky, Boris
Kattan, Michael W.
Kalaycio, Matt E.
Sekeres, Mikkael A.
BRITISH JOURNAL OF HAEMATOLOGY, 2007, 137 (02) : 125 - 132
[40] A decision analysis to determine the appropriate treatment for low-risk myelodysplastic syndromes.
Sekeres, MA
Fu, AZ
Maciejewski, JP
Golshayan, AR
Kalaycio, M
Kattan, MW
BLOOD, 2005, 106 (11) : 711A - 711A

← 1 2 3 4 5 →